Viewing Study NCT00546156


Ignite Creation Date: 2025-12-24 @ 11:15 PM
Ignite Modification Date: 2026-02-25 @ 6:43 PM
Study NCT ID: NCT00546156
Status: COMPLETED
Last Update Posted: 2021-05-18
First Post: 2007-10-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer
Sponsor: Ian E. Krop, MD, PhD
Organization: